Little Green Pharma will produce a range of Medicinal Cannabis preparations with differing cannabinoid profiles from different plant varieties. All of our products are relatively low in the psychoactive cannabinoid THC.
Little Green Pharma is a privately-owned company based in Western Australia. The company has been granted a license by the federal Office of Drug Control (ODC) to cultivate and produce Medicinal Cannabis from 1st June 2017 for Australian patients.
There is growing evidence that Medicinal Cannabis can benefit patients in a variety of clinical settings:
- Chronic Pain
- Multiple Sclerosis
- Palliative care
Our manufacturing breakthrough aims to control the Medicinal Cannabis particle size encapsulated in the liposomes to optimise the bio-availability so the cannabinoids are readily absorbed into the bloodstream.
ensures therapeutic effectiveness can be
achieved with low dosage so less cannabis is needed.
Precise control of dosage
gives the medical practitioner better control of the effects of the medicine and helps researchers to more accurately assess the effects in clinical trials.
Full plant cannabinoid profile
our manufacturing process preserves the full cannabinoid profile found in the source plant – it does not decarboxylate the acid forms of the cannabinoids unless decarboxylation is specifically intended. Research suggests that the full plant profile is important through the “entourage effect”.